Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Canal

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Journal De Pharmacologie|November 1, 1981
[Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)]G Akel, P Canal, R Bugat, et al.
Seminars in Hematology|April 1, 1994
Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantationD Schlaifer, M Attal, F Huguet, et al.
Archives Francaises De Pediatrie|November 1, 1970
[Suicide attempt in children]D Lonchamp, J P Canal, J Schirrer, et al.
Annales De Biologie Clinique|January 1, 1990
[Statement: alkaline phosphatases. Genetic aspects. Identification and clinical interpretation]G Favre, P Canal, G Soula, et al.
Anti-Cancer Drugs|September 23, 2000
Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitro-phenylacetate converting carboxylesterase activityI Hennebelle, C Terret, E Chatelut, et al.
Journal De Pharmacologie|January 1, 1983
Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing ratsG Akel, P Canal, E Mockey, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Pharmacokinetics and efficacy of i.v. and i.p. VM26 chemotherapy in mice bearing Krebs II ascitic tumorsP Canal, R Bugat, B Rokoszak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
How to predict carboplatin clearance from standard morphological and biological characteristics in obese patientsS Bénézet, R Guimbaud, E Chatelut, et al.
Annales De Biologie Clinique|January 1, 1985
[Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia]H Hachem, G Raynal, G Favre, et al.
Journal of the National Cancer Institute|October 6, 1993
Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiencyP Houyau, C Gay, E Chatelut, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Journal De Pharmacologie|November 1, 1981
[Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)]G Akel, P Canal, R Bugat, et al.
Seminars in Hematology|April 1, 1994
Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in refractory lymphoma patients undergoing autologous bone marrow transplantationD Schlaifer, M Attal, F Huguet, et al.
Archives Francaises De Pediatrie|November 1, 1970
[Suicide attempt in children]D Lonchamp, J P Canal, J Schirrer, et al.
Annales De Biologie Clinique|January 1, 1990
[Statement: alkaline phosphatases. Genetic aspects. Identification and clinical interpretation]G Favre, P Canal, G Soula, et al.
Anti-Cancer Drugs|September 23, 2000
Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitro-phenylacetate converting carboxylesterase activityI Hennebelle, C Terret, E Chatelut, et al.
Journal De Pharmacologie|January 1, 1983
Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing ratsG Akel, P Canal, E Mockey, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Pharmacokinetics and efficacy of i.v. and i.p. VM26 chemotherapy in mice bearing Krebs II ascitic tumorsP Canal, R Bugat, B Rokoszak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1997
How to predict carboplatin clearance from standard morphological and biological characteristics in obese patientsS Bénézet, R Guimbaud, E Chatelut, et al.
Annales De Biologie Clinique|January 1, 1985
[Determination of serum apolipoproteins A1 and B by immunoturbidimetry using the Cobas-Bio centrifugal analyzer. Influence of hyperlipemia]H Hachem, G Raynal, G Favre, et al.
Journal of the National Cancer Institute|October 6, 1993
Severe fluorouracil toxicity in a patient with dihydropyrimidine dehydrogenase deficiencyP Houyau, C Gay, E Chatelut, et al.
Pageof 15